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Abstract
Background: Smoking cessation during pregnancy and 
preventing relapse postpartum is a pivotal public health pri-
ority. Objectives: This study examined the risk and protec-
tive indicators of women who (a) smoke before pregnancy, 
(b) smoke during the entire pregnancy, (c) successfully quit 
smoking during pregnancy, and (d) relapse postpartum. 
Method: This paper reports secondary analyses of the Dutch 
population-based Monitor on Substance Use and Pregnan-
cy (2016). A representative sample of mothers of young chil-
dren (n = 1,858) completed questionnaires at youth health 
care centers. Bivariate and multivariate logistic regression 
analyses were conducted. Results: Main results showed that 
women’s smoking around pregnancy was strongly associ-
ated with the partner’s smoking status before pregnancy, 
partner’s change in smoking during pregnancy, and part-
ner’s change in smoking postpartum. Women’s educational 
level and cannabis use before pregnancy were also related 
with women’s smoking before and during pregnancy. 
Women’s intensity of alcohol use before pregnancy was am-
biguously related with women’s smoking before and during 
pregnancy. Conclusions: One of the key findings of this 
study suggests that it is essential that partners quit smoking 
before pregnancy and do not smoke during pregnancy. If 
partners continue smoking during pregnancy, they should 
quit smoking postpartum. Health care professionals can 
play an important role in addressing partners’ smoking and 
giving them evidence-based cessation support before, dur-
ing, and after pregnancy. © 2019 The Author(s)
Published by S. Karger AG, Basel
Introduction
Smoking during pregnancy and relapse postpartum is 
a major public health concern [1, 2]. Smoking during 
pregnancy has detrimental health effects on women’s 
pregnancies (e.g., pre-term birth and low birth weight) 
[3] as well as on infants’ and children’s physical health 
and cognitive and social development (e.g., neurodevel-
This article is licensed under the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (CC BY-
NC-ND) (http://www.karger.com/Services/OpenAccessLicense). 
Usage and distribution for commercial purposes as well as any dis-
tribution of modified material requires written permission.
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opmental and behavioral problems) [3–6]. In addition, 
children’s exposure to secondhand smoke has been asso-
ciated with, among other risks, increased frequency of 
asthma [3, 7] and an increased risk that children will start 
smoking in the future [8]. 
Pregnancy could serve as a teachable moment for 
women to quit smoking [9]. This argument is supported 
by recent research showing that women are more likely 
to quit smoking during pregnancy than before pregnan-
cy [10]. Nonetheless, many women continue to smoke 
during pregnancy. A large study using representative na-
tional samples from 54 low- and middle-income coun-
tries provided evidence that the pooled prevalence of any 
tobacco use in pregnancy was 2.6%, with the highest 
prevalence in Turkey (15.0%) [11]. Moreover, postpar-
tum relapse rates of women who quit smoking during 
pregnancy are also high. A meta-analysis showed that 
43% of women who stopped smoking during pregnancy 
began smoking again at 6 months postpartum [12]. In 
addition, subgroup analyses of this meta-analysis re-
vealed that the rate of women who relapsed at 6 months 
postpartum increased to 74% when only studies with 
biochemically validated abstinence data were included 
[12].
Multiple smoking cessation and relapse prevention in-
terventions for pregnant women have been developed and 
tested [13–15], but evidence for their effectiveness is 
mixed. A Cochrane review illustrated that psychosocial 
interventions could decrease the number of women who 
smoke in late pregnancy by 35% [16]. In addition, finan-
cial incentives and interventions that included feedback 
(e.g., information about fetal health status) have proven 
effective in reducing the prevalence of smoking women in 
late pregnancy [16]. In contrast, postpartum relapse pre-
vention interventions have shown limited effects [2, 17]. 
It seems that many women and their offspring do not re-
ceive the maximum health benefits of smoking cessation 
[12]. Therefore, there is still considerable room for im-
provement with regard to cessation and relapse-preven-
tion interventions in pregnancy. Effectiveness might be 
improved by tailoring interventions toward specific char-
acteristics, risk and protective indicators, and needs of the 
target group. Multiple systematic reviews and meta-anal-
yses have shown that tailored (vs. non-tailored) health 
promotion interventions are more effective [18–20].
In order to provide women who smoke with tailored 
and (cost-)effective help to quit smoking before and dur-
ing pregnancy and to avoid postpartum relapse, a pro-
found understanding of this specific population is essen-
tial. So far, many studies have examined different charac-
teristics of women who either (1) smoked before or during 
pregnancy, (2) quit smoking during pregnancy, or (3) re-
lapsed postpartum. A large study focusing on smoking 
before pregnancy found that women who did not take fo-
lic acid, who had a low educational level, who had an un-
planned pregnancy, and who lived alone were more likely 
to smoke before pregnancy [21]. Other studies found that 
women who were younger [22–24], were unmarried, or 
lived alone [21, 23, 25], had a low educational level [21–
26], lived in an extended family [23], did not take folic acid 
[21], and had partners who smoked [25] were more likely 
to smoke during pregnancy. In addition, women were 
more likely to quit smoking during pregnancy when they 
were married [27], had a higher socioeconomic status 
[22], had a higher educational level [27–29], lived with a 
non-smoking cohabitant [27, 29], and smoked fewer ciga-
rettes before pregnancy or quitting [27]. Finally, women 
were more likely to relapse postpartum when they quit 
smoking during instead of before pregnancy [30, 31], did 
not breastfeed [30, 32], had a smoking environment at 
home [30, 32], had more family and friends who smoked, 
had a partner that continued smoking during pregnancy, 
smoked more cigarettes per day before pregnancy, and 
were younger and unmarried [31]. To conclude, the ma-
jority of studies solely examined the associations between 
risk indicators and women’s smoking behavior with re-
spect to one or 2 moments around women’s pregnancy 
(e.g., before or during pregnancy). Only 2 studies exam-
ined risk and protective indicators at all points around 
pregnancy (i.e., before, during, and after) in the same 
study. However, the data in these 2 studies were collected 
more than 20 years ago and lacked findings on smoking 
during pregnancy [33] or combined smoking before and 
during pregnancy [34]. Moreover, most studies mainly 
focused on sociodemographic indicators and less on part-
ner’s smoking status or other maternal substance use (e.g., 
alcohol and cannabis) around pregnancy. The combina-
tion of looking at all three points around pregnancy and 
including various indicators provides a more complete 
picture of whether (change in) behavior of women and 
their context before pregnancy is associated with smoking 
of women later on during or after pregnancy.
The current study uses cross-sectional data of a repre-
sentative population-based study from the Netherlands 
(i.e., the Monitor on Substance Use and Pregnancy) to 
exploratively examine demographic, substance-use-re-
lated, and pregnancy-related risk and protective indica-
tors of women who (a) smoke before pregnancy, (b) 
smoke during the entire pregnancy, (c) successfully quit 
smoking during pregnancy, and (d) relapse postpartum. 
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The use of a large representative sample, a broad spec-
trum of indicators (i.e., sociodemographic, partner’s 
smoking behavior around pregnancy, and other maternal 
substance use), and the measurement of 3 time points 
around pregnancy helps to gain insight into the charac-
teristics of women who smoke around pregnancy and 
provides information on whether the characteristics dif-
fer over the 3 time points around pregnancy. These in-
sights may contribute to the development of tailored ces-
sation and relapse-prevention interventions. 
Materials and Methods
Sample
The Dutch Monitor on Substance Use and Pregnancy [35] is 
a representative population-based cross-sectional study in which 
mothers have to answer questions retrospectively about their 
substance use (i.e., smoking, drinking, and drug use) before, dur-
ing, and after pregnancy. For the present study, we used only the 
data collected in 2016 (the Monitor will be repeated in 2018). In 
the Netherlands, all children up to 18 years old receive preventive 
health care at youth health care (YHC) centers [36]. Therefore, 
to collect a sample that properly represented mothers with young 
children (i.e., youngest child younger than 5 years) and to maxi-
mize the chance that mothers with a low socioeconomic status 
would participate in this study, mothers were  recruited at YHC 
centers. A total of 34 cities across the Netherlands were random-
ly selected to be approached for participation in the Monitor. In 
total, 27 (79.4%) of these cities agreed to participate, and their 
YHC centers were included. For the 7 cities that did not want to 
participate, other cities of similar urbanicity in the same region 
were approached, and all YHC centers in these cities registered 
for participation. In total, 46 YHC centers, distributed through-
out 35 cities in the Netherlands,  participated.
The cluster sampling strategy resulted in a representative sam-
ple of Dutch mothers with young children with some small devia-
tions. For instance, the percentage of Western mothers in this sam-
ple was higher than that of the entire Dutch population (86.8 vs. 
80.5%). After being weighted for age, educational level, and ethnic-
ity, the sample properly represented Dutch mothers with young 
children. In total, 1,858 mothers (M 31.69, SD 4.69) were included. 
The average age of the youngest child was 11.14 months (SD 12.22). 
Data Collection
Data were collected in November and December 2016. Moth-
ers who visited a YHC center with their child were asked whether 
they would like to participate in a study on health behaviors of 
mothers of young children. To participate, participants needed to 
be a mother of children aged 0–4 years. There were no exclusion 
criteria. Mothers received oral instructions by trained research as-
sistants and gave permission to participate in our study (active 
informed consent). Participation included that mothers filled out 
a short questionnaire (∼5 min) at the YHC center while waiting 
for their appointment. The response rate was 94.2%. Some moth-
ers declined to participate because they could not speak Dutch flu-
ently. Mothers who did not agree to participate due to a lack of 
time were offered the opportunity to fill out a paper or online ver-
sion of the questionnaire later at home. Participants filled out the 
questionnaire on a tablet (84.4%), paper (13.6%), or online (2.0%). 
Because of the sensitivity of this study’s topic and to minimize so-
cially desirable answers, research assistants approached the moth-
ers and emphasized that the data would be collected and processed 
anonymously. 
Measures
In the questionnaire, maternal smoking status was assessed 
with respect to three different time points around the pregnancy: 
before, during, and after pregnancy. With respect to the maternal 
status before pregnancy, mothers were asked whether they had 
smoked in the four weeks before their pregnancy. Smoking during 
pregnancy was measured for each trimester separately (1–3 
months; 4–6 months; 7–9 months), by asking mothers whether 
they had smoked at all during each trimester. Smoking status after 
pregnancy was assessed by asking whether they had smoked in the 
past four weeks. Four groups were constructed (Fig. 1). From the 
total sample, the first group consisted out of women who smoked 
in the four weeks before pregnancy (reference group: women who 
did not smoke before pregnancy). From this first group, a second 
group was selected including women who successfully quit smok-
ing at some point during pregnancy through the end of the preg-
nancy (i.e., did not smoke in the third trimester; reference group: 
women who did not successfully quit smoking during pregnancy). 
From the second group we selected a third group, consisting out 
of women who had successfully quit smoking during pregnancy, 
but relapsed postpartum (reference group: women who success-
fully quit smoking during pregnancy and remained smoke-free 
postpartum). Finally, a fourth group was constructed, including 
women who smoked during the entire pregnancy (i.e., all three 
trimesters; reference group: women who did not smoke or who 
only smoked before pregnancy or who smoked less than three tri-
mesters during pregnancy). Women could belong to more than 
one group. For instance, women who successfully quit smoking at 
some point during the pregnancy could also belong to the group 
of women who relapsed after pregnancy (Fig. 1).”
Several maternal sociodemographic indicators were assessed, 
including age (four categories), educational level (low: primary ed-
ucation or pre-secondary vocational education/medium: second-
ary (vocational) education/high: higher vocational education or 
university), ethnicity (Dutch/other-Western/non-Western), and 
living situation (partner and children/other). The following risk 
and protective indicators were measured: 1) breastfeeding (yes/
no); 2) intake of folic acid before and during pregnancy (yes/no); 
3) intensity of alcohol use before pregnancy (i.e., number of glasses 
alcohol consumed on days that women drank alcohol before preg-
nancy: non-drinkers, 1 glass, ≥2 glasses); 4) alcohol use during 
pregnancy (yes/no); 5) cannabis use before pregnancy (yes/no); 6) 
partner’s smoking status before pregnancy (yes/no); 7) change in 
partner’s smoking behavior during pregnancy (compared to before 
pregnancy: partner did not smoke before and during pregnancy/
partner’s smoking decreased or partner quit smoking during preg-
nancy/partner smoked as much or more during pregnancy); 8) 
change in partner’s smoking behavior postpartum (compared to 
before and during pregnancy: partner did not smoke before, dur-
ing, and after pregnancy/partner smoked before or during preg-
nancy but not after pregnancy/partner smoked after pregnancy); 
9) talked about smoking cessation with a health care professional 
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during pregnancy (yes/no); and 10) use of smoking cessation sup-
port during pregnancy (yes/no). Breastfeeding included any breast-
feeding without a required minimum duration. Use of smoking 
cessation support during pregnancy (e.g., nicotine replacement 
therapy, behavioral coaching, and e-health interventions) was cat-
egorized “yes” if mothers checked at least one of the cessation sup-
port answer options on the question whether they had used any of 
the following smoking cessation support options. If mothers indi-
cated that they had not used any support, it was categorized “no”. 
Because this study aimed to be nationally representative and the 
data were collected when mothers were waiting for their appoint-
ment at the YHC centers, the questionnaire was very short and no 
data were collected on e.g. nicotine dependence, mental health dis-
orders or other indicators related to smoking behavior.
Statistical Analyses
In order to control for the clustered sampling procedure and to 
ensure that the data were representative of Dutch women with 
young children, all analyses were carried out using the Complex 
Samples Module of the software program Statistical Package for the 
Social Sciences, version 20. Because most questionnaires were col-
lected digitally, missing data was not an issue. First, frequencies were 
calculated to provide characteristics of the 4 groups. Note that these 
groups could not be compared, as women could belong to 2 or more 
groups. Next, to determine the most important indicators related to 
the 4 groups, a 2-stage approach was carried out. First, bivariate lo-
gistic regression models were used for each outcome variable. If the 
p value of the bivariate model (BM) was lower than 0.05, it was con-
sidered statistically significant. Second, multivariate logistic regres-
sion models were built for the 4 groups. The significant indicators 
from the BM were entered simultaneously in the multivariate mod-
els (MM). Adjusted ORs, 95% CIs, and  values are reported. 
Results
Table 1 presents the weighted descriptive statistics for 
the risk and protective indicators for the total sample and 
for each group. Of the 1,858 women who participated in 
this study, 358 women (20.2%) reported that they had 
smoked at some time around pregnancy. More specifi-
cally, 17.4% smoked before pregnancy, 4.9% smoked dur-
ing the entire pregnancy, 12.0% successfully quit smoking 
during pregnancy, and 5.5% successfully quit smoking 
during pregnancy but relapsed postpartum. Of the wom-
en who successfully quit smoking during pregnancy, 
46.1% relapsed postpartum. In total, 82.3% of these wom-
en relapsed within 6 months postpartum. 
Indicators Associated with Women who Smoked 
before Pregnancy
Table 2 presents the BM and MM of risk and protective 
indicators that were associated with women who smoked 
before pregnancy. According to the BM, women who 
smoked before pregnancy were younger, less educated, 
and lived without a partner more often compared to 
women who did not smoke before pregnancy. In addi-
tion, women who smoked before pregnancy less often 
took folic acid before pregnancy, more often used sub-
stances before pregnancy (i.e., higher intensity of alcohol 
use, any cannabis use), and more often had a partner who 
Total sample
(n = 1,858)
No smoking
(n = 1,547)
No entire
(n = 1,765)
Before
pregnancy
During
pregnancy
After
pregnancy
Entire
(n = 84)
Not quit
(n = 93)
No relapse
(n = 118)
Relapse
(n = 97)
Quit
(n = 216)
Smoking
(n = 311)
1 missing
2 missings
9 missings
Fig. 1. The 4 groups of women that were 
constructed to include in the analyses.
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Table 1. Descriptive statistics for demographic and other indicators for total sample and each group
Indicators Total
sample, 
n (%)
Women who
smoked BP,
n (%)* Women whosmoked duringthe entire
pregnancy, n (%)*
Women who
successfully quit 
smoking DP, n (%)* Women whorelapsed PP, n (%)*
Number 1,858 311 84 216 97
Maternal age, years
18–24 127 (8.7) 44 (17.0) 14 (20.4) 25 (14.1) 8 (9.6)
25–29 455 (28.6) 102 (35.8) 28 (34.7) 69 (35.9) 38 (44.8)
30–34 739 (38.4) 100 (30.1) 20 (23.0) 80 (34.2) 33 (30.8)
35+ 528 (24.4) 65 (17.1) 22 (21.8) 42 (15.7) 18 (14.8)
Educational level
Low 153 (11.8) 48 (19.8) 26 (36.4) 23 (14.6) 13 (18.8)
Medium 705 (38.1) 170 (52.5) 50 (55.1) 110 (49.3) 57 (53.7)
High 1,000 (50.1) 93 (27.7) 8 (8.4) 83 (36.1) 27 (27.5)
Living situation
Partner and children 1,735 (92.0) 258 (81.1) 66 (76.1) 183 (83.0) 80 (80.8)
Other 123 (8.0) 53 (18.9) 18 (23.9) 33 (17.0) 17 (19.2)
Ethnicity
Dutch 1,469 (69.4) 256 (74.7) 71 (79.0) 175 (72.4) 78 (71.6)
Other Western 144 (10.6) 26 (11.4) 6 (9.6) 19 (12.1) 6 (9.0)
Other non-Western 244 (20.0) 29 (13.9) 7 (11.4) 22 (15.5) 13 (19.4)
Intake of folic acid BP
No 569 (33.1) 130 (44.5) 24 (32.6) 99 (48.3) 39 (44.8)
Yes 1,289 (66.9) 181 (55.5) 60 (67.4) 117 (51.7) 58 (55.2)
Intake of folic acid DP
No 133 (8.6) 23 (8.3) 11 (14.6) 12 (6.1) 4 (5.0)
Yes 1,718 (91.4) 286 (91.7) 73 (85.4) 204 (93.9) 93 (95.0)
Breastfeeding
No 490 (26.1) 123 (38.9) 45 (50.8) 71 (32.2) 35 (35.7)
Yes 1,351 (73.9) 185 (61.1) 39 (49.2) 144 (67.8) 62 (64.3)
Intensity of alcohol use BP
Non-drinkers 1,012 (57.2) 123 (40.4) 64 (75.0) 56 (27.0) 27 (29.2)
1 glass 415 (21.5) 63 (21.7) 7 (9.5) 53 (26.3) 27 (29.7)
≥2 glasses 423 (21.3) 125 (38.0) 13 (15.5) 107 (46.7) 43 (41.1)
Alcohol use DP
No 1,757 (95.4) 291 (94.6) 80 (95.7) 203 (94.5) 93 (95.4)
Yes 91 (4.6) 17 (5.4) 4 (4.3) 12 (5.5) 4 (4.6)
Cannabis use BP
No 1,818 (97.8) 285 (90.2) 78 (91.3) 200 (90.7) 87 (86.3)
Yes 33 (2.2) 25 (9.8) 6 (8.7) 16 (9.3) 10 (13.7)
Smoking of partner BP
No 1,345 (71.1) 97 (30.8) 18 (23.4) 76 (34.1) 29 (27.8)
Yes 510 (28.9) 214 (69.2) 66 (76.6) 140 (65.9) 68 (72.2)
Change in partner’s smoking DP
compared to BP
Did not smoke BP and DP 1,335 (71.7) 106 (34.6) 21 (26.7) 82 (38.2) 31 (30.7)
Decreased or quit 230 (13.0) 92 (29.4) 22 (24.7) 67 (31.3) 29 (32.1)
As much as or increased 268 (15.3) 107 (36.0) 41 (48.6) 62 (30.5) 35 (37.2)
Change in partner’s smoking PP 
Did not smoke at all 1,336 (72.3) 124 (41.2) 28 (36.5) 95 (44.6) 39 (39.4)
Smoked BP or DP, but not PP 76 (4.1) 24 (7.0) 4 (4.5) 21 (8.9) 2 (1.8)
Smoked PP 419 (23.6) 159 (51.8) 52 (59.0) 98 (46.5) 55 (58.8)
Talked about smoking cessation
with health care professionals DP
No 253 (80.3) 249 (80.9) 48 (56.9) 197 (92.3) 84 (91.0)
Yes 59 (19.7) 56 (19.1) 36 (43.1) 15 (7.7) 9 (9.0)
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smoked before pregnancy. Most associations remained 
significant in the MM except younger age and the use of 
folic acid before pregnancy. 
Indicators Associated with Women who Smoked 
during the Entire Pregnancy
The BM shows that women who smoked during 
the  entire pregnancy were younger, less educated and 
lived without a partner more often than women who did 
not smoke during the entire pregnancy (Table 2). In ad-
dition, they were more likely to have a lower intensity of 
alcohol use before pregnancy and use any cannabis be-
fore pregnancy than women who did not smoke during 
the entire pregnancy. Lastly, women who did (vs. did 
not) smoke during the entire pregnancy were more like-
ly to have a partner who smoked during the pregnancy. 
In the MM, low educational level, living without a part-
ner, and smoking of the partner during pregnancy re-
mained significantly associated with smoking of the 
mother during the entire pregnancy. Finally, the inten-
sity of alcohol use before pregnancy appears to be a pro-
tective indicator; that is, women who smoked during the 
entire pregnancy were more likely to have a lower inten-
sity of alcohol use before pregnancy than women who 
did not smoke during the entire  pregnancy. 
Indicators Associated with Women who Successfully 
Quit Smoking during Pregnancy
Table 3 presents the BM and MM of risk and protec-
tive indicators associated with women who successfully 
quit smoking during pregnancy. The BM showed that 
women who did (vs. did not) successfully quit smoking 
during pregnancy were more likely to have a higher edu-
cational level, a higher intensity of alcohol use before 
pregnancy, and a partner who did not smoke before and 
during pregnancy or who cut down on smoking during 
pregnancy. In addition, women who did (vs. did not) 
successfully quit smoking during pregnancy were less 
likely to have talked about smoking cessation with a 
health care professional or used smoking cessation sup-
port during pregnancy. In the MM, a high educational 
level and a higher intensity of alcohol use before preg-
nancy remained significantly associated with successful-
ly quitting during pregnancy, as well as a lower rate of 
talking with a health care professional and no use of 
smoking cessation support. 
Indicators Associated with Women who 
Relapsed Postpartum
According to the BM, maternal age was significantly re-
lated to relapsing postpartum. In addition, women who 
relapsed postpartum more often had a partner who contin-
ued smoking postpartum or who did not smoke at all (ver-
sus a partner who quit smoking postpartum) compared to 
women who did not relapse postpartum (Table 3). In the 
MM, only the partner’s smoking behavior postpartum re-
mained significant. It appears that women who relapsed 
postpartum more often had a partner who continued 
smoking postpartum or a partner who did not smoke at all 
compared to women who did not relapse postpartum. 
Discussion/Conclusion
This study offers a different and unique perspective by 
drawing together risk and protective indicators for before, 
during, and after pregnancy as a combined analysis in one 
single sample. Moreover, a broad set of indicators was ex-
Indicators Total
sample, 
n (%)
Women who
smoked BP,
n (%)* Women whosmoked duringthe entire
pregnancy, n (%)*
Women who
successfully quit 
smoking DP, n (%)* Women whorelapsed PP, n (%)*
Use of smoking cessation support DP
No 295 (93.6) 288 (94.0) 74 (89.2) 207 (96.8) 91 (95.5)
Yes 22 (6.4) 20 (6.0) 10 (10.8) 8 (3.2) 5 (4.5)
The percentages are weighted for age, educational level, and ethnicity.* Does not add to the subsample size due to missing values.
BP, before pregnancy; DP, during pregnancy; PP, postpartum
Table 1. (continued)
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Table 2. Indicators associated with women who smoked before pregnancy (n = 311) versus women who did not smoke before preg-
nancy (n = 1,547) and with women who smoked during the entire pregnancy (n = 84) versus women who did not smoke during the 
entire pregnancy (n = 1,765)
Indicators Smoking BP Smoking during the entire pregnancy
BM MM BM MM
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
Maternal age, years <0.001 0.10 0.004 0.43
18–24 3.73 (2.20–6.32) 1.78 (0.88–3.61) 2.83 (1.38–5.79) 1.19 (0.49–2.90)
25–29 2.00 (1.41–2.84) 1.37 (0.95–1.99) 1.37 (0.81–2.33) 0.88 (0.48–1.59)
30–34 1.13 (0.82–1.56) 0.97 (0.69–1.35) 0.66 (0.38–1.14) 0.72 (0.37–1.43)
35+ 1 1 1 1
Educational level <0.001 <0.001 <0.001 <0.001
Low 3.88 (2.56–5.89) 3.05 (1.88–4.96) 21.29 (8.47–53.50) 11.30 (4.31–29.62)
Medium 2.96 (2.21–3.96) 2.84 (2.02–4.00) 9.15 (4.06–20.61) 5.20 (2.12–12.73)
High 1 1 1 1
Living situation <0.001 <0.001 <0.001 0.002
Partner and children 1 1 1 1
Other 3.83 (2.76–5.31) 2.38 (1.54–3.66) 4.01 (2.42–6.66) 2.42 (1.40–4.17)
Ethnicity 0.16 – 0.08 –
Dutch 1.68 (0.98–2.91) 2.05 (1.11–3.78)
Other Western 1.69 (0.76–3.75) 1.61 (0.56–4.59)
Other non-Western 1 1
Intake of folic acid BP <0.001 0.48 0.94 –
No 1.81 (1.34–2.46) 1.14 (0.79–1.66) 0.98 (0.54–1.76)
Yes 1 1 1
Intake of folic acid DP – – 0.11 –
No 1.90 (0.86–4.22)
Yes 1
Intensity of alcohol use BP <0.001 <0.001 0.01 0.02
Non-drinkers 1 1 1 1
1 glass 1.52 (1.01–2.28) 2.11 (1.39–3.21) 0.32 (0.14–0.76) 0.41 (0.18–0.90)
≥2 glasses 3.21 (2.42–4.27) 4.61 (3.23–6.58) 0.54 (0.32–0.91) 0.56 (0.33–0.94)
Alcohol use DP – – 0.91 –
No 1
Yes 0.93 (0.27–3.28)
Cannabis use BP <0.001 <0.001 0.001 0.09
No 1 1 1 1
Yes 18.31 (6.54–51.25) 9.85 (3.53–27.44) 5.03 (2.00–12.66) 3.13 (0.83–11.75)
Smoking of partner BP <0.001 <0.001 – –
No 1 1
Yes 8.79 (6.94–11.14) 6.78 (5.30–8.68)
Change in partner’s smoking
DP compared to BP
– <0.001 <0.001
Did not smoke 
BP and DP 1 1
Decreased or quit 5.53 (2.84–10.76) 4.42 (2.33–8.42)
As much as or
increased 
9.87 (6.68–17.49) 7.50 (4.05–13.89)
The outcome variables were categorized as “smoking four weeks before pregnancy” (yes = 1; no = 0) and “smoking during the entire pregnancy (i.e., during 
all three trimesters)” (yes = 1; no = 0).
BM, bivariate model; MM, multivariate model; BP, before pregnancy; DP, during pregnancy; PP, postpartum. 
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amined, including sociodemographic indicators, women’s 
substance use, smoking behavior of the partner around 
pregnancy, and use of smoking cessation support. A major 
finding of this study is that the relationship between the 
partner’s smoking status and the smoking status of women 
around pregnancy cannot be underestimated. Women who 
smoked before pregnancy were nearly 7 times more likely 
to have a partner who smoked before pregnancy compared 
to women who did not smoke before pregnancy. Similarly, 
two thirds of the women who smoked during the entire 
pregnancy also had a partner who smoked during pregnan-
cy. Women who did (vs. did not) smoke during the entire 
pregnancy were 7.5 times more likely to have a partner who 
smoked as much as before pregnancy or increased smoking 
during pregnancy. In addition, women who did (vs. did 
not) smoke during the entire pregnancy were nearly 4.5 
times more likely to have a partner who decreased their 
smoking or quit smoking during pregnancy. Finally, wom-
en who did (vs. did not) relapse postpartum were nearly 
twice as likely to have a partner who continued smoking 
postpartum. These findings are consistent with prior stud-
ies [24, 25, 27, 32, 37] and provide more insight into the re-
lationship between the timing of the partner’s smoking be-
havior and maternal smoking status around pregnancy 
(e.g., women who smoked during the entire pregnancy were 
nearly 4.5 times more likely to have a partner who decreased 
their smoking or quit smoking during pregnancy compared 
to women who did not smoke during the entire pregnancy).
Another important finding of this study is the one that 
highlights the profound association between women’s 
educational level and their smoking status before and 
during pregnancy. This study found that women who did 
(vs. did not) smoke before pregnancy were about 3 times 
more likely to have a low or medium educational level. In 
addition, women who did (vs. did not) smoke during the 
entire pregnancy were nearly 11.5 times more likely to 
have a low educational level and more than 5 times more 
likely to have a medium educational level. Conversely, 
women who did (vs. did not) successfully quit smoking 
during pregnancy were more than 4 times more likely to 
be highly educated. These findings are in line with previ-
ous studies [21, 23, 25–27, 34] and emphasize that more 
attention is needed to help women with a lower educa-
tional level to quit smoking before and during pregnancy.
With respect to the impact of maternal substance use 
on smoking around pregnancy, our findings showed that 
women who did (vs. did not) smoke before pregnancy 
were nearly 10 times more likely to have also used can-
nabis before pregnancy. This study adds to the evidence 
that cannabis and tobacco are concurrently used among In
di
ca
to
rs
Su
cc
es
sf
ul
ly
 q
ui
tti
ng
 sm
ok
in
g 
du
ri
ng
 p
re
gn
an
cy
Re
la
ps
in
g 
po
st
pa
rt
um
BM
M
M
BM
M
M
O
R 
(9
5%
 C
I)
p 
va
lu
e
O
R 
(9
5%
 C
I)
p 
va
lu
e
O
R 
(9
5%
 C
I)
p 
va
lu
e
O
R 
(9
5%
 C
I)
p 
va
lu
e
C
ha
ng
e 
in
 p
ar
tn
er
’s 
sm
ok
in
g 
PP
  
–
–
0.
00
2
0.
00
5
D
id
 n
ot
 sm
ok
e 
at
 a
ll
1
1
Sm
ok
ed
 B
P 
or
 D
P,
 b
ut
 n
ot
 P
P 
0.
15
 (0
.3
0–
7.
38
)
0.
17
 (0
.0
3–
0.
85
)
Sm
ok
ed
 P
P
2.
03
 (1
.0
7–
3.
82
)
1.
94
 (1
.0
4–
3.
63
)
Ta
lk
ed
 a
bo
ut
 sm
ok
in
g 
ce
ss
at
io
n 
w
ith
 
he
al
th
 c
ar
e 
pr
of
es
sio
na
ls 
D
P
<0
.0
01
<0
.0
01
0.
49
–
N
o
1
1
0.
71
 (0
.2
6–
1.
92
)
Ye
s
0.
10
 (0
.0
6–
0.
18
)
0.
12
 (0
.0
5–
0.
27
)
1
U
se
 o
f s
m
ok
in
g 
ce
ss
at
io
n 
su
pp
or
t D
P
0.
00
3
0.
00
6
0.
36
–
N
o
1
1
0.
45
 (0
.0
8–
2.
50
)
Ye
s
0.
24
 (0
.1
0–
0.
60
)
0.
18
 (0
.0
6–
0.
59
)
1
Th
e 
ou
tc
om
e 
va
ri
ab
le
s w
er
e 
ca
te
go
ri
ze
d 
as
 “S
m
ok
in
g 
be
fo
re
 p
re
gn
an
cy
, s
uc
ce
ss
fu
lly
 q
ui
tti
ng
 a
t s
om
e 
tim
e 
du
ri
ng
 p
re
gn
an
cy
 th
ro
ug
h 
th
e 
en
d 
of
 th
e 
pr
eg
na
nc
y 
(i.
e.
, d
id
 n
ot
 sm
ok
e 
in
 th
e 
th
ir
d 
tr
i-
m
es
te
r)
” (
ye
s =
 1
; n
o 
= 
0)
 a
nd
 “S
m
ok
in
g 
be
fo
re
 p
re
gn
an
cy
, s
uc
ce
ss
fu
lly
 q
ui
tti
ng
 sm
ok
in
g 
du
ri
ng
 p
re
gn
an
cy
 (i
.e
., 
di
d 
no
t s
m
ok
e 
du
ri
ng
 a
t l
ea
st
 th
e 
th
ir
d 
tr
im
es
te
r)
, b
ut
 re
la
ps
in
g 
po
st
pa
rt
um
” (
ye
s =
 1
; 
no
 =
 0
).
BM
, b
iv
ar
ia
te
 m
od
el
; M
M
, m
ul
tiv
ar
ia
te
 m
od
el
; B
P,
 b
ef
or
e 
pr
eg
na
nc
y;
 D
P,
 d
ur
in
g 
pr
eg
na
nc
y;
 P
P,
 p
os
tp
ar
tu
m
. 
Ta
b
le
 3
. (
co
nt
in
ue
d)
Indicators of Women’s Smoking Behavior 
before, During, and after Pregnancy
141Eur Addict Res 2019;25:132–144
DOI: 10.1159/000498988
women around pregnancy [38, 39]. The role of intensity 
of alcohol use before pregnancy on smoking around preg-
nancy was ambiguous. On the one hand, women who did 
(vs. did not) smoke before pregnancy were more likely to 
have a higher intensity of alcohol use before pregnancy. 
On the other hand, women who did (vs. did not) success-
fully quit smoking during pregnancy were more likely to 
have a higher intensity of alcohol use before pregnancy. 
Although women’s educational level might play a role 
here (more educated individuals tend to drink more alco-
hol than less educated individuals) [40], the MM demon-
strated that the relationship between intensity of alcohol 
use and women’s smoking status is maintained even 
when taking women’s educational level into account. 
Therefore, it is difficult to comprehend these mixed re-
sults, and more research is needed on the relationship be-
tween women’s intensity of alcohol use before pregnancy 
and women’s smoking behavior around pregnancy.
Two other contrasting findings of this study showed 
that women who did (vs. did not) successfully quit smok-
ing during pregnancy had talked about smoking cessa-
tion with a health care professional during pregnancy less 
often and also used smoking cessation support during 
pregnancy less often. However, a Cochrane review re-
vealed that smokers who quit smoking more often talked 
about smoking cessation with health care professionals 
[41]. In addition, research has shown that smokers are 
much more likely to quit smoking when they receive 
smoking cessation support (e.g., telephone counseling) 
[42]. Our findings could be caused by a selection effect. 
That is, it may be the case that health care professionals 
mostly talked about smoking cessation with women who 
were more addicted to smoking and therefore found it 
more difficult to quit smoking. Likewise, smoking cessa-
tion support may have been mostly used by women who 
were more addicted to smoking. 
Strengths and Limitations
A major strength of this study concerns the recruit-
ment strategy. In the Netherlands, nearly all parents visit 
YHC centers regularly so that their children’s physical 
and social development can be monitored [36]. Because 
women were recruited at YHC centers that were random-
ly selected at the city level, this study was able to recruit a 
sample that was largely representative of Dutch women 
with young children. Another strength is that we includ-
ed some indicators (e.g., change in partner’s smoking 
during and after pregnancy) in the analyses that, as far as 
we know, have not been examined before. Because of this, 
we were able to examine whether any change in partners’ 
smoking around pregnancy affected women’s smoking 
status around pregnancy. This investigation resulted in 
some new insights concerning the association between 
partners’ smoking behavior and women’s smoking status 
around pregnancy (e.g., women were less likely to smoke 
during the entire pregnancy when their partner decreased 
their smoking or quit smoking during pregnancy com-
pared to women whose partner smoked as much as or 
increased their smoking during pregnancy). These in-
sights could be important for the development and/or im-
provement of smoking cessation and relapse prevention 
interventions that are tailored to this specific group. A 
limitation of this study is that the data were collected at 
one moment (i.e., cross-sectional), so no causal relations 
can be concluded. In addition, two of the examined indi-
cators (i.e., alcohol use during pregnancy and change in 
partner’s smoking postpartum) had cell values < 5 in some 
of the investigated groups (e.g., women who relapsed 
postpartum). Therefore, caution is needed in interpreting 
these results. A third limitation is that the data were self-
reported and not biochemically validated. Biochemical 
validation was impossible due to the study design. In self-
report, an important source of underreporting is related 
to the social-desirability bias [43], which should be mini-
mized as far as possible. The fact that 94.2% of the women 
who were approached agreed to participate in this study 
illustrates that they were willing to provide answers on 
this sensitive topic. Moreover, the questionnaires were 
completely anonymous (i.e., names and contact informa-
tion were not collected) and the women filled in the ques-
tionnaires by themselves to further decrease such bias. A 
fourth limitation is that the data were retrospectively ob-
tained, which could make them subject to recall bias. 
However, several studies have provided evidence that re-
call on smoking behavior during pregnancy is quite ac-
curate [44, 45]. Ergin et al. [44] assumed that this accu-
racy is a result of the social stigma associated with smok-
ing during pregnancy and the fact that pregnancy is 
experienced as an important life event. 
Implications for Practice
This study emphasizes the importance of having a 
smoke-free partner at all points around pregnancy. More 
specifically, our results suggest that it is essential that part-
ners who smoke quit smoking before pregnancy and do 
not smoke during pregnancy. Still, when partners are not 
able or willing to quit smoking before or during pregnan-
cy, it is pivotal for partners to be encouraged to quit smok-
ing postpartum, since women who relapsed postpartum 
more often had a partner who continued smoking post-
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partum compared to women who did not relapse postpar-
tum. Based on these findings, it might not be sufficient for 
health care professionals to address partners’ smoking 
and provide them with effective cessation support exclu-
sively during pregnancy. Instead, it is necessary for health 
care professionals to also address partners’ smoking be-
havior and provide them with evidence-based cessation 
support before and after pregnancy. A systematic review 
found 9 studies that tested smoking cessation interven-
tions for partners of pregnant women [46]. Only two of 
these studies (in which partners received, e.g., nicotine 
replacement therapy) yielded positive results on partner’s 
smoking cessation [47, 48]. However, there was no evi-
dence that these results were maintained postpartum (i.e., 
one study did not examine this [47], and the other study 
did not report these results [48]). The postpartum period 
could serve as a key time-point to provide partners smok-
ing with cessation interventions, since at this time-point 
partners have a heightened awareness that being a smok-
er is in conflict with being a “good parent”[49]. Thus, fur-
ther research should not exclusively focus on developing 
and examining smoking cessation interventions for part-
ners during pregnancy. Instead, the main focus of further 
intervention research should be to examine how partners 
can abstain from smoking before and after pregnancy.
Finally, this study underlines that women who smoked 
before pregnancy more often used cannabis and/or had a 
high intensity of alcohol use before pregnancy than wom-
en who did not smoke before pregnancy. Research showed 
that concurrently continuing to both smoke and use oth-
er substances (such as alcohol and cannabis) during preg-
nancy can have serious adverse health effects for women’s 
pregnancies and their fetuses [50]. In many cases, women 
do not know that they are pregnant during the first few 
weeks of their pregnancy. Therefore, in order to limit 
women’s concurrent substance use during these early 
weeks of pregnancy, it is important that women of child-
bearing age who use substances concurrently receive in-
formation on the importance of quitting smoking and 
other substances before pregnancy. 
Acknowledgement
Not applicable. 
Ethics Statement
Participants have given their written informed consent. In ad-
dition, the Ethics Committee of the Trimbos Institute has ap-
proved the study protocol of the Dutch Monitor on Substance Use 
and Pregnancy. 
Disclosure Statement
The authors declare that they have no conflicts of interest to 
disclose. 
Funding Sources
This work was supported by the Dutch Ministry of Health, 
Welfare, and Sport and the Dutch Cancer Society (grant number: 
2015-7944). The funding bodies had no role in the design of the 
study and collection, analysis, and interpretation of data, and in 
writing the manuscript.
Authors Contribution
M.T. was responsible for the recruitment and data collection. 
T.S.S. was responsible for the analyses and report of the study re-
sults. R.O., R.E., and M.K. were supervisors. All authors read and 
approved of the final manuscript.
References
 1 Riaz M, Lewis S, Naughton F, Ussher M. Pre-
dictors of smoking cessation during pregnan-
cy: a systematic review and meta-analysis. 
Addiction. 2018 Apr; 113(4): 610–22.
 2 Levitt C, Shaw E, Wong S, Kaczorowski J; Mc-
Master University Postpartum Research 
Group. Systematic review of the literature on 
postpartum care: effectiveness of interven-
tions for smoking relapse prevention, cessa-
tion, and reduction in postpartum women. 
Birth. 2007 Dec; 34(4): 341–7.
 3 Hofhuis W, de Jongste JC, Merkus PJ. Ad-
verse health effects of prenatal and postnatal 
tobacco smoke exposure on children. Arch 
Dis Child. 2003 Dec; 88(12): 1086–90.
 4 Ekblad M, Korkeila J, Lehtonen L. Smoking 
during pregnancy affects foetal brain devel-
opment. Acta Paediatr. 2015 Jan; 104(1): 12–
8.
 5 Ekblad M, Gissler M, Lehtonen L, Korkeila 
J. Prenatal smoking exposure and the risk of 
psychiatric morbidity into young adulthood. 
Arch Gen Psychiatry. 2010 Aug; 67(8): 841–
9.
 6 Williams GM, O’Callaghan M, Najman JM, 
Bor W, Andersen MJ, Richards D, et al. Ma-
ternal cigarette smoking and child psychiatric 
morbidity: a longitudinal study. Pediatrics. 
1998 Jul; 102(1):e11.
 7 DiFranza JR, Aligne CA, Weitzman M. Pre-
natal and postnatal environmental tobacco 
smoke exposure and children’s health. Pedi-
atrics. 2004 Apr; 113(4 Suppl): 1007–15.
 8 Leonardi-Bee J, Jere ML, Britton J. Expo-
sure  to parental and sibling smoking and 
the  risk of smoking uptake in childhood 
and  adolescence: a systematic review and 
meta-analysis. Thorax. 2011 Oct; 66(10): 
847–55.
Indicators of Women’s Smoking Behavior 
before, During, and after Pregnancy
143Eur Addict Res 2019;25:132–144
DOI: 10.1159/000498988
 9 McBride CM, Emmons KM, Lipkus IM. Un-
derstanding the potential of teachable mo-
ments: the case of smoking cessation. Health 
Educ Res. 2003 Apr; 18(2): 156–70.
10 Crozier SR, Robinson SM, Borland SE, God-
frey KM, Cooper C, Inskip HM; SWS Study 
Group. Do women change their health 
 behaviours in pregnancy? Findings from 
the Southampton Women’s Survey. Paedi-
atr Perinat Epidemiol. 2009 Sep; 23(5): 446–
53.
11 Caleyachetty R, Tait CA, Kengne AP, Corva-
lan C, Uauy R, Echouffo-Tcheugui JB. Tobac-
co use in pregnant women: analysis of data 
from Demographic and Health Surveys from 
54 low-income and middle-income coun-
tries. Lancet Glob Health. 2014 Sep; 
2(9):e513–20.
12 Jones M, Lewis S, Parrott S, Wormall S, Cole-
man T. Re-starting smoking in the postpar-
tum period after receiving a smoking cessa-
tion intervention: a systematic review. Addic-
tion. 2016 Jun; 111(6): 981–90.
13 Donatelle RJ, Prows SL, Champeau D, Hud-
son D. Randomised controlled trial using so-
cial support and financial incentives for high 
risk pregnant smokers: significant other sup-
porter (SOS) program. Tob Control. 2000; 
9(90003 Suppl 3):III67–9.
14 Hannöver W, Thyrian JR, Röske K, Grempler 
J, Rumpf HJ, John U, et al. Smoking cessation 
and relapse prevention for postpartum wom-
en: results from a randomized controlled trial 
at 6, 12, 18 and 24 months. Addict Behav. 
2009 Jan; 34(1): 1–8.
15 Reitzel LR, Vidrine JI, Businelle MS, Kend-
zor DE, Costello TJ, Li Y, et al. Preventing 
postpartum smoking relapse among diverse 
low-income women: a randomized clinical 
trial. Nicotine Tob Res. 2010 Apr; 12(4): 326–
35.
16 Chamberlain C, O’Mara-Eves A, Porter J, 
Coleman T, Perlen SM, Thomas J, et al. Psy-
chosocial interventions for supporting 
women to stop smoking in pregnancy. Co-
chrane Database Syst Rev. 2017 Feb; 2: 
CD001055.
17 Hajek P, Stead LF, West R, Jarvis M, Hart-
mann-Boyce J, Lancaster T. Relapse preven-
tion interventions for smoking cessation. Co-
chrane Database Syst Rev. 2013 Aug;(8): 
CD003999.
18 Krebs P, Prochaska JO, Rossi JS. A meta-anal-
ysis of computer-tailored interventions for 
health behavior change. Prev Med. 2010 Sep-
Oct; 51(3-4): 214–21.
19 Noar SM, Benac CN, Harris MS. Does tailor-
ing matter? Meta-analytic review of tailored 
print health behavior change interventions. 
Psychol Bull. 2007 Jul; 133(4): 673–93.
20 Lustria ML, Noar SM, Cortese J, Van Stee SK, 
Glueckauf RL, Lee J. A meta-analysis of web-
delivered tailored health behavior change in-
terventions. J Health Commun. 2013; 18(9): 
1039–69.
21 Smedberg J, Lupattelli A, Mårdby AC, 
 Nordeng H. Characteristics of women who 
continue smoking during pregnancy: a 
cross-sectional study of pregnant women 
and new mothers in 15 European countries. 
BMC Pregnancy Childbirth. 2014 Jun; 14(1): 
213.
22 Mohsin M, Bauman AE. Socio-demographic 
factors associated with smoking and smoking 
cessation among 426,344 pregnant women in 
New South Wales, Australia. BMC Public 
Health. 2005 Dec; 5(1): 138.
23 Nur N. Association of risk factors with smok-
ing during pregnancy among women of child-
bearing age: an epidemiological field study in 
Turkey. Sao Paulo Med J. 2017 Mar-Apr; 
135(2): 100–6.
24 Xu H, Wen LM, Rissel C, Baur LA. Smoking 
status and factors associated with smoking of 
first-time mothers during pregnancy and 
postpartum: findings from the Healthy Be-
ginnings Trial. Matern Child Health J. 2013 
Aug; 17(6): 1151–7.
25 Penn G, Owen L. Factors associated with con-
tinued smoking during pregnancy: analysis of 
socio-demographic, pregnancy and smoking-
related factors. Drug Alcohol Rev. 2002 Mar; 
21(1): 17–25.
26 Härkönen J, Lindberg M, Karlsson L, Karls-
son H, Scheinin NM. Education is the stron-
gest socio-economic predictor of smoking in 
pregnancy. Addiction. 2018 Jun; 113(6): 
1117–26.
27 Kia F, Tosun N, Carlson S, Allen S. Examin-
ing characteristics associated with quitting 
smoking during pregnancy and relapse post-
partum. Addict Behav. 2018 Mar; 78: 114–
119. 
28 Connor SK, McIntyre L. The sociodemo-
graphic predictors of smoking cessation 
among pregnant women in Canada. Can J 
Public Health. 1999 Sep-Oct; 90(5): 352–5.
29 Lu Y, Tong S, Oldenburg B. Determinants of 
smoking and cessation during and after preg-
nancy. Health Promot Int. 2001 Dec; 16(4): 
355–65.
30 Polanska K, Hanke W, Sobala W, Lowe JB, 
Jaakkola JJ. Predictors of smoking relapse af-
ter delivery: prospective study in central Po-
land. Matern Child Health J. 2011 Jul; 15(5): 
579–86.
31 Solomon LJ, Higgins ST, Heil SH, Badger GJ, 
Thomas CS, Bernstein IM. Predictors of post-
partum relapse to smoking. Drug Alcohol De-
pend. 2007 Oct; 90(2-3): 224–7.
32 Simmons VN, Sutton SK, Quinn GP, Meade 
CD, Brandon TH. Prepartum and postpar-
tum predictors of smoking. Nicotine Tob Res. 
2014 Apr; 16(4): 461–8.
33 Colman GJ, Joyce T. Trends in smoking be-
fore, during, and after pregnancy in ten states. 
Am J Prev Med. 2003 Jan; 24(1): 29–35.
34 Kahn RS, Certain L, Whitaker RC. A reexam-
ination of smoking before, during, and after 
pregnancy. Am J Public Health. 2002 Nov; 
92(11): 1801–8.
35 Tuithof M, Siauw R, Van Dorsselaer S, Mon-
shouwer K. Factsheet Monitor Zwangerschap 
en Middelengebruik Het middelengebruik van 
moeders en hun partner voor, tijdens en na de 
zwangerschap. Utrecht; 2017. Available from: 
https://assets.trimbos.nl/docs/3600fc07-
b31b-4505-9664-6d48ec07eadc.pdf.
36 Nederlands Centrum Jeugdgezondheid 
(NCJ). Landelijk professioneel kader: Uitvo-
ering basispakket jeugdgezondheidszorg 
(JGZ). Utrecht; 2018. Available from: https://
assets.ncj.nl/docs/9c8aba38-2e8d-4fef-a346-
ab7dab7f8bc3.pdf.
37 Orton S, Coleman T, Coleman-Haynes T, 
Ussher M. Predictors of Postpartum Return 
to Smoking: A Systematic Review. Nicotine 
Tob Res. 2018 May; 20(6): 665–73.
38 Passey ME, Sanson-Fisher RW, D’Este 
CA, Stirling JM. Tobacco, alcohol and can-
nabis use during pregnancy: clustering of 
risks. Drug Alcohol Depend. 2014 Jan; 134: 
44–50.
39 El Marroun H, Tiemeier H, Jaddoe VW, Hof-
man A, Mackenbach JP, Steegers EA, et al. 
Demographic, emotional and social determi-
nants of cannabis use in early pregnancy: the 
Generation R study. Drug Alcohol Depend. 
2008 Dec; 98(3): 218–26.
40 van Laar MW, van Gestel B, Cruts AA, van 
der Pol PM, Ketelaars AP, Beenakkers EM, et 
al. Nationale Drug Monitor: Jaarbericht 
2017. Utrecht; 2017. Available from: www.
wodc.nl.
41 Stead LF, Buitrago D, Preciado N, Sanchez 
G, Hartmann-Boyce J, Lancaster T. Physi-
cian advice for smoking cessation. Co-
chrane Database Syst Rev. 2013 May;(5): 
CD000165.
42 Stead LF, Koilpillai P, Fanshawe TR, Lancast-
er T. Combined pharmacotherapy and behav-
ioural interventions for smoking cessation. 
Cochrane Database Syst Rev. 2016 Mar 24; 
3:CD008286. 
43 Schneider S, Schütz J. Who smokes during 
pregnancy? A systematic literature review of 
population-based surveys conducted in de-
veloped countries between 1997 and 2006. 
Eur J Contracept Reprod Health Care. 2008 
Jun; 13(2): 138–47.
44 Ergin I, Hassoy H, Tanik FA, Aslan G. Ma-
ternal age, education level and migration: 
socioeconomic determinants for smoking 
during pregnancy in a field study from Tur-
key. BMC Public Health. 2010 Jun; 10(1): 
325.
45 Hensley Alford SM, Lappin RE, Peterson L, 
Johnson CC. Pregnancy associated smoking 
behavior and six year postpartum recall. 
Matern Child Health J. 2009 Nov; 13(6): 
865–72.
46 Hemsing N, Greaves L, O’Leary R, Chan 
K,  Okoli C. Partner support for smoking 
cessation during pregnancy: a systematic re-
view. Nicotine Tob Res. 2012 Jul; 14(7): 767–
76.
47 Stanton WR, Lowe JB, Moffatt J, Del Mar CB. 
Randomised control trial of a smoking cessa-
tion intervention directed at men whose part-
ners are pregnant. Prev Med. 2004 Jan; 38(1): 
6–9.
Scheffers-van Schayck/Tuithof/Otten/
Engels/Kleinjan
Eur Addict Res 2019;25:132–144144
DOI: 10.1159/000498988
48 McBride CM, Baucom DH, Peterson BL, Pol-
lak KI, Palmer C, Westman E, et al. Prenatal 
and postpartum smoking abstinence a part-
ner-assisted approach. Am J Prev Med. 2004 
Oct; 27(3): 232–8.
49 Flemming K, Graham H, McCaughan D, An-
gus K, Bauld L. The barriers and facilitators to 
smoking cessation experienced by women’s 
partners during pregnancy and the post-par-
tum period: a systematic review of qualitative 
research. BMC Public Health. 2015 Sep; 15(1): 
849.
50 Viteri OA, Soto EE, Bahado-Singh RO, Chris-
tensen CW, Chauhan SP, Sibai BM. Fetal 
anomalies and long-term effects associated 
with substance abuse in pregnancy: a literature 
review. Am J Perinatol. 2015 Apr; 32(5): 405–
16.
